Navigation Links
Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery
Date:12/17/2008

SAN DIEGO, Dec. 17 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) today announced positive topline results from Study 304, a Phase III clinical trial of Acetavance(TM), the company's intravenous formulation of acetaminophen, for the treatment of acute pain following abdominal laparoscopic surgery. Study 304 successfully met its primary endpoint of a statistically significant reduction in summed pain intensity differences from baseline over 24 hours (SPID24) for Acetavance 1000 mg compared to placebo (p < 0.01).

Study 304 was a randomized, double-blind, multi-center study of 244 patients designed to evaluate the safety and efficacy of two dosing regimens of Acetavance, 1000 mg every six hours and 650 mg every four hours, compared to placebo over 24 hours. In addition to the 1000 mg dose administered every six hours meeting the primary endpoint, the trial also achieved a statistically significant reduction in SPID24 for the 650mg dose administered every four hours (p = 0.02). Consistent with other placebo-controlled clinical trials with intravenous acetaminophen, reported safety events from the Acetavance and placebo treated patients were similar. The company plans to communicate the full study results in a peer-reviewed venue.

Cadence also announced today that Study 351, a clinical trial evaluating the safety of repeated doses of Acetavance in adults, demonstrated a hepatic and general safety profile of Acetavance comparable to control (standard of care), with numerically lower proportions of subjects with elevated liver function tests in the two Acetavance groups compared to the standard of care group. Study 351 was an open-label, multi-center study of 213 hospitalized patients randomized to receive repeated doses of Acetavance 1000mg every six hours, Acetavance 650mg every four hours, or
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Cadence Pharmaceuticals Chief Medical Officer James Breitmeyer to Present at JMP Securities Healthcare Focus Conference
2. Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
3. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results and Provides Corporate and Clinical Program Overview
4. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter Financial Results and Provide a Clinical Program Update on May 6, 2008
5. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 11, 2008 in New York
6. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
7. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
11. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... 05, 2015 , ... Renowned review site BestMillionaireDatingSites.com recently refreshed its list of ... been ranked as the best dating service in the segment. , A representative from ... is essential that people find the right dating platform so that they can make ...
(Date:8/4/2015)... ... August 04, 2015 , ... NOVA Pride , Northern ... or how they love or identify, to join them in paving “The Road Ahead” ... Special Events Center on Saturday, October 3, 2015, from 12-9pm. In order to ensure ...
(Date:8/4/2015)... ... , ... Statement by Paul Gionfriddo, President and CEO, Mental Health America , ... Act of 2015 by Senators Bill Cassidy and Christopher Murphy. It is ... , “This legislation and H.R. 2646 [The Helping Families in Mental Health ...
(Date:8/4/2015)... ... August 04, 2015 , ... Sponsored by Gila River ... which is a 501(c) nonprofit organization. , According to the New Foundation AZ ... will get a package that includes a complimentary foursome for the tournament, as well ...
(Date:8/4/2015)... ... August 04, 2015 , ... Exsurco Medical, Inc. ... Tissue Banks (AATB) as an Affiliate Member. Exsurco Medical finds this an ... save and improve lives by promoting the safety, quality and availability of donated ...
Breaking Medicine News(10 mins):Health News:BestMillionaireDatingSites.com Publishes Reviews of the Best Dating Sites for Wealthy Singles 2Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 2Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 3Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 4Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 3Health News:The New Foundation AZ to Host Charity Golf Tournament 2Health News:The New Foundation AZ to Host Charity Golf Tournament 3Health News:Exsurco Medical Joins AATB as Affiliate Member 2
... a new definition to identify children and adolescents ... diabetes and cardiovascular disease in later life. The ... ,The metabolic syndrome is a cluster of the most ... disease. Its early identification is very important to facilitate ...
... Rachel Hunter became quite worried about her weight after a ... ,The former wife of rocker Rod Stewart is the ... that she was really concerned about her weight when the ... what's wrong with me? Do I look fat," Contactmusic quoted ...
... annual HealthGrades Womens Health Outcomes in U.S. Hospitals ... nation's best- performing hospitals have a 39 percent ... women at the nation's poorest-performing hospitals. ... largest quality gaps between the best-performing and poorest-performing ...
... reportedly planning to undergo a foot surgery . ... because of her painful bunions and has decided to get ... enough of having bad feet and has made some early-stage ... Mail quoted the source, as saying. ,"They are ...
... Mumbai, June 25 (IANS) Indian pharmaceutical major Ranbaxy Laboratories ... pravastatin sodium tablets, meant for heart diseases . ... 180-day exclusivity for the pravastatin 80mg and benefit from ... Bombay Stock Exchange (BSE). ,The annual sales ...
... is more effective than one-on-one phone counseling. As Americans ... provide feedback and motivation can play a crucial role ... ,Researchers found feedback delivered via mail was equally ... and potentially more effective long-term than feedback delivered via ...
Cached Medicine News:Health News:New Definition Helps Identify Children at Risk of Metabolic Syndrome 2Health News:Best-performing Hospitals Has Reduced Cardiovascular Mortality 2Health News:Physical Activity can Be Increased by a Motivating Mail 2Health News:Physical Activity can Be Increased by a Motivating Mail 3
(Date:8/4/2015)...  Eli Lilly and Company (NYSE: LLY ) ... of its intent to end its contract with the ... Asymptomatic Alzheimer,s disease (A4) study. The A4 study is ... stage of Alzheimer,s disease in older individuals who have ... scan, but do not show symptoms of memory impairment. ...
(Date:8/4/2015)... 4, 2015  Sangamo BioSciences, Inc. (NASDAQ: SGMO ... Ch.B., Sangamo,s executive vice president, research and development, will ... Therapeutic ® development programs and an overview of ... August 11, 2015, at the 2015 Wedbush Pacgrow Healthcare ... New York, NY . The presentation ...
(Date:8/4/2015)... Calif., Aug. 4, 2015  Xencor, Inc. (NASDAQ: ... engineered monoclonal antibodies for the treatment of autoimmune ... reported financial results for the second quarter ended June ... business highlights. "Currently eight XmAb® antibody ... and two internal. The accelerating momentum of this ...
Breaking Medicine Technology:Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 2Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 3Sangamo BioSciences Announces Presentation At The 2015 Wedbush Pacgrow Healthcare Conference 2Xencor Reports Second Quarter 2015 Financial and Operating Results 2Xencor Reports Second Quarter 2015 Financial and Operating Results 3Xencor Reports Second Quarter 2015 Financial and Operating Results 4Xencor Reports Second Quarter 2015 Financial and Operating Results 5Xencor Reports Second Quarter 2015 Financial and Operating Results 6Xencor Reports Second Quarter 2015 Financial and Operating Results 7Xencor Reports Second Quarter 2015 Financial and Operating Results 8Xencor Reports Second Quarter 2015 Financial and Operating Results 9
... ago, Keli Babcock faced a crisis. A medical condition was ... a ventilator. She couldn,t walk or even maneuver a manual ... But Keli wasn,t about to give in; she aspired to ... with a power wheelchair, one that is powered by batteries ...
... Innovative wireless technology is reshaping the healthcare landscape in ... of Wireless" webcast ( www.ctia.org ) focuses on new ... more value and better health. This is particularly true ... of the U.S. population suffers from at least one ...
Cached Medicine Technology:Mobility Matters: Power Wheelchairs Change the Lives of Medicare Beneficiaries 2Mobility Matters: Power Wheelchairs Change the Lives of Medicare Beneficiaries 3Mobility Matters: Power Wheelchairs Change the Lives of Medicare Beneficiaries 4CTIA-The Wireless Association® November Edition of 'Wonder of Wireless' and Blog to Focus on mHealth 2CTIA-The Wireless Association® November Edition of 'Wonder of Wireless' and Blog to Focus on mHealth 3
... The Tomey Pachymeter SP-3000 covers all ... the general ophthalmic health care., ,Compact design, ... the SP-3000 to be an "easy-to-use unit.,The ... 1500 mm gives you the possibility to ...
The PillCam™ ESO video capsule is specifically designed to view the inner lining of the Esophagus. The capsule is equipped with miniature cameras on both ends and is about the size of a multi-v...
... combines three advanced technologies - plus ... refractive diagnostic workstation. Now, with a ... corneal topography, optical path difference (OPD) ... allows you to evaluate your patient ...
World's first commercially available vacuum assisted biopsy device for MRI....
Medicine Products: